Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Towards a rational approach to vaccine development.

Leclerc C.

Hum Vaccin. 2010 Apr;6(4):292-6. Epub 2010 Apr 17. No abstract available.

PMID:
20372073
2.

DC-based cancer vaccines: lessons from clinical trials.

Brody JD, Engleman EG.

Cytotherapy. 2004;6(2):122-7. Review. No abstract available.

PMID:
15203988
3.

DNA vaccines for cancer too.

Yu M, Finn OJ.

Cancer Immunol Immunother. 2006 Feb;55(2):119-30. Epub 2005 Jul 20. Review. No abstract available.

PMID:
16032397
4.

Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations.

Hamdy S, Haddadi A, Hung RW, Lavasanifar A.

Adv Drug Deliv Rev. 2011 Sep 10;63(10-11):943-55. doi: 10.1016/j.addr.2011.05.021. Epub 2011 Jun 6. Review.

PMID:
21679733
5.

The molecular basis of cancer immunotherapy by cytotoxic T lymphocytes.

Lindauer M, Stanislawski T, Häussler A, Antunes E, Cellary A, Huber C, Theobald M.

J Mol Med (Berl). 1998 Jan;76(1):32-47. Review.

PMID:
9462866
6.

Potential approaches for more successful dendritic cell-based immunotherapy.

Chiang CL, Balint K, Coukos G, Kandalaft LE.

Expert Opin Biol Ther. 2015 Apr;15(4):569-82. doi: 10.1517/14712598.2015.1000298. Epub 2015 Jan 2. Review.

PMID:
25553913
7.

Dendritic cell-based vaccines: from mouse models to clinical cancer immunotherapy.

Schreurs MW, Eggert AA, Punt CJ, Figdor CG, Adema GJ.

Crit Rev Oncog. 2000;11(1):1-17. Review.

PMID:
10795625
8.

Idiotype vaccination strategies in myeloma: how to overcome a dysfunctional immune system.

Rhee Fv.

Clin Cancer Res. 2007 Mar 1;13(5):1353-5. Review. No abstract available.

9.

Dendritic cells in cancer vaccines.

Brossart P, Wirths S, Brugger W, Kanz L.

Exp Hematol. 2001 Nov;29(11):1247-55. Review.

PMID:
11698120
10.

The use of dendritic cells in cancer immunotherapy.

Schuler G, Schuler-Thurner B, Steinman RM.

Curr Opin Immunol. 2003 Apr;15(2):138-47. Review.

PMID:
12633662
11.

Immunotherapy of hematological malignancies using dendritic cells.

Van de Velde AL, Berneman ZN, Van Tendeloo VF.

Bull Cancer. 2008 Mar;95(3):320-6. doi: 10.1684/bdc.2008.0602. Review.

12.

Dendritic cell-based immunization for cancer therapy.

Morse MA, Lyerly HK.

Adv Exp Med Biol. 2000;465:335-46. Review. No abstract available.

PMID:
10810637
13.

Dendritic cells and immunotherapy for malignant disease.

Reid DC.

Br J Haematol. 2001 Mar;112(4):874-87. Review. No abstract available.

PMID:
11298582
14.

Combination strategies for enhancing the efficacy of immunotherapy in cancer patients.

Moschella F, Proietti E, Capone I, Belardelli F.

Ann N Y Acad Sci. 2010 Apr;1194:169-78. doi: 10.1111/j.1749-6632.2010.05464.x. Review.

PMID:
20536466
15.

Dendritic cells in tumor immunology and immunotherapy.

Turtle CJ, Hart DN.

Curr Drug Targets. 2004 Jan;5(1):17-39. Review.

PMID:
14738216
16.

Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?

Shurin MR, Gregory M, Morris JC, Malyguine AM.

Expert Opin Biol Ther. 2010 Nov;10(11):1539-53. doi: 10.1517/14712598.2010.526105. Review.

PMID:
20955111
17.

Cancer vaccines.

Bonnefoy JY.

Expert Opin Ther Targets. 2004 Dec;8(6):521-5. Review.

PMID:
15584859
18.

Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies.

Klippstein R, Pozo D.

Nanomedicine. 2010 Aug;6(4):523-9. doi: 10.1016/j.nano.2010.01.001. Epub 2010 Jan 18. Review.

PMID:
20085824
19.

Immunotherapy with dendritic cells as a cancer treatment: perspectives and therapeutic potential.

Aleixo AA, Michelin MA, Murta EF.

Recent Pat Endocr Metab Immune Drug Discov. 2013 Sep;7(3):226-32. Review.

PMID:
23675964
20.

Dendritic cells and cancer immunotherapy.

Radford KJ, Tullett KM, Lahoud MH.

Curr Opin Immunol. 2014 Apr;27:26-32. doi: 10.1016/j.coi.2014.01.005. Epub 2014 Feb 8. Review.

PMID:
24513968

Supplemental Content

Support Center